BOSTON SCIENTIFIC CORPORATION Increase (Decrease) in Operating Liabilities
BOSTON SCIENTIFIC CORPORATION (BSX) reported Increase (Decrease) in Operating Liabilities of -$18.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2020-02-25
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in operating liabilities for fiscal 2019 was -$18.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in operating liabilities for fiscal 2018 was -$1.16B, a 4257.14% decline from fiscal 2017.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in operating liabilities for fiscal 2017 was $28.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in operating liabilities for fiscal 2016 was -$128.00M, a 137.98% decline from fiscal 2015.
| Period end | Increase (Decrease) in Operating Liabilities 12 month |
|---|---|
| 2019-12-31 | -$18.00M 10-K · filed 2020-02-25 |
| 2018-12-31 | -$1.16B 10-K · filed 2020-02-25 |
| 2017-12-31 | $28.00M 10-K · filed 2020-02-25 |
| 2016-12-31 | -$128.00M 10-K · filed 2019-02-19 |
| 2015-12-31 | $337.00M 10-K · filed 2018-02-20 |
| 2014-12-31 | $403.00M 10-K · filed 2017-02-23 |
| 2013-12-31 | $209.00M 10-K · filed 2016-02-24 |
| 2012-12-31 | $380.00M 10-K · filed 2015-02-25 |
| 2011-12-31 | $106.00M 10-K · filed 2014-02-26 |
| 2010-12-31 | -$404.00M 8-K · filed 2013-05-29 |
| 2009-12-31 | $278.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |